Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah et al. · Pharmaceutical Research · 1995 · 5.3K citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

Marc Maliepaard, George L. Scheffer, Ian F. Faneyte et al. · PubMed · 2001 · 1.1K citations

Medicine, Cancer Biology, Oncology +14

British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

B G Gazzard · HIV Medicine · 2008 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Catia Marzolini, Amalio Telenti, Laurent A. Décosterd et al. · AIDS · 2001 · 836 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

Jacques Fellay, Catia Marzolini, E. Rhiannon Meaden et al. · The Lancet · 2002 · 662 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17